
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expression and regulation of non‐classical HLA‐G in renal cell carcinoma
K. Dunker, Gerald Schlaf, Juergen Bukur, et al.
Tissue Antigens (2008) Vol. 72, Iss. 2, pp. 137-148
Closed Access | Times Cited: 58
K. Dunker, Gerald Schlaf, Juergen Bukur, et al.
Tissue Antigens (2008) Vol. 72, Iss. 2, pp. 137-148
Closed Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
Marco Campoli, Soldano Ferrone
Oncogene (2008) Vol. 27, Iss. 45, pp. 5869-5885
Open Access | Times Cited: 379
Marco Campoli, Soldano Ferrone
Oncogene (2008) Vol. 27, Iss. 45, pp. 5869-5885
Open Access | Times Cited: 379
The immunology of renal cell carcinoma
C. Marcela Díaz‐Montero, Brian I. Rini, James H. Finke
Nature Reviews Nephrology (2020) Vol. 16, Iss. 12, pp. 721-735
Closed Access | Times Cited: 343
C. Marcela Díaz‐Montero, Brian I. Rini, James H. Finke
Nature Reviews Nephrology (2020) Vol. 16, Iss. 12, pp. 721-735
Closed Access | Times Cited: 343
HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Cancer and Pregnancy: Parallels in Growth, Invasion, and Immune Modulation and Implications for Cancer Therapeutic Agents
Shernan G. Holtan, Douglas J. Creedon, Paul Haluska, et al.
Mayo Clinic Proceedings (2009) Vol. 84, Iss. 11, pp. 985-1000
Open Access | Times Cited: 273
Shernan G. Holtan, Douglas J. Creedon, Paul Haluska, et al.
Mayo Clinic Proceedings (2009) Vol. 84, Iss. 11, pp. 985-1000
Open Access | Times Cited: 273
The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Insights into HLA-G Genetics Provided by Worldwide Haplotype Diversity
Erick C. Castelli, Jaqueline Ramalho, Iane de Oliveira Pires Porto, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 128
Erick C. Castelli, Jaqueline Ramalho, Iane de Oliveira Pires Porto, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 128
Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation
Cristina Grange, Marta Tapparo, Stefania Tritta, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 112
Cristina Grange, Marta Tapparo, Stefania Tritta, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 112
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Non‐classical transcriptional regulation of HLA‐G: an update
Philippe Moreau, Sébastien Flajollet, Edgardo D. Carosella
Journal of Cellular and Molecular Medicine (2009) Vol. 13, Iss. 9b, pp. 2973-2989
Open Access | Times Cited: 103
Philippe Moreau, Sébastien Flajollet, Edgardo D. Carosella
Journal of Cellular and Molecular Medicine (2009) Vol. 13, Iss. 9b, pp. 2973-2989
Open Access | Times Cited: 103
Human Leukocyte Antigen-G Protein Expression Is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma following Curative Resection
Ming‐Yan Cai, Yongfeng Xu, Shuang‐Jian Qiu, et al.
Clinical Cancer Research (2009) Vol. 15, Iss. 14, pp. 4686-4693
Open Access | Times Cited: 96
Ming‐Yan Cai, Yongfeng Xu, Shuang‐Jian Qiu, et al.
Clinical Cancer Research (2009) Vol. 15, Iss. 14, pp. 4686-4693
Open Access | Times Cited: 96
Role of DNA methylation in renal cell carcinoma
Niraj Shenoy, Nishanth Vallumsetla, Yiyu Zou, et al.
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 82
Niraj Shenoy, Nishanth Vallumsetla, Yiyu Zou, et al.
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 82
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
Niraj Shenoy, Lance C. Pagliaro
Annals of Oncology (2016) Vol. 27, Iss. 9, pp. 1685-1695
Open Access | Times Cited: 73
Niraj Shenoy, Lance C. Pagliaro
Annals of Oncology (2016) Vol. 27, Iss. 9, pp. 1685-1695
Open Access | Times Cited: 73
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Michael Friedrich, Simon Jasinski‐Bergner, Maria‐Filothei Lazaridou, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 10, pp. 1689-1700
Closed Access | Times Cited: 62
Michael Friedrich, Simon Jasinski‐Bergner, Maria‐Filothei Lazaridou, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 10, pp. 1689-1700
Closed Access | Times Cited: 62
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
Marcus Bauer, Simon Jasinski‐Bergner, Ofer Mandelboim, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5189-5189
Open Access | Times Cited: 53
Marcus Bauer, Simon Jasinski‐Bergner, Ofer Mandelboim, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5189-5189
Open Access | Times Cited: 53
Inflammatory Networks in Renal Cell Carcinoma
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 17
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 17
Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses
Ana Paula Duarte de Souza, Cristina Bonorino
Expert Review of Anticancer Therapy (2009) Vol. 9, Iss. 9, pp. 1317-1332
Closed Access | Times Cited: 71
Ana Paula Duarte de Souza, Cristina Bonorino
Expert Review of Anticancer Therapy (2009) Vol. 9, Iss. 9, pp. 1317-1332
Closed Access | Times Cited: 71
HLA-E expression and its clinical relevance in human renal cell carcinoma
Barbara Seliger, Simon Jasinski‐Bergner, Dagmar Quandt, et al.
Oncotarget (2016) Vol. 7, Iss. 41, pp. 67360-67372
Open Access | Times Cited: 57
Barbara Seliger, Simon Jasinski‐Bergner, Dagmar Quandt, et al.
Oncotarget (2016) Vol. 7, Iss. 41, pp. 67360-67372
Open Access | Times Cited: 57
Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma
Cristina Grange, Alessia Brossa, Benedetta Bussolati
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1832-1832
Open Access | Times Cited: 48
Cristina Grange, Alessia Brossa, Benedetta Bussolati
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1832-1832
Open Access | Times Cited: 48
Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma
Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 22, pp. 4983-4994
Open Access | Times Cited: 25
Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 22, pp. 4983-4994
Open Access | Times Cited: 25
HLA-G in organ transplantation: towards clinical applications
Frédéric Deschaseaux, Diego Delgado, Vito Pistoia, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 397-404
Open Access | Times Cited: 56
Frédéric Deschaseaux, Diego Delgado, Vito Pistoia, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 397-404
Open Access | Times Cited: 56
Inhibition of human Vγ9Vδ2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer
Emilie Lesport, Jérémy Baudhuin, Sylvie Sousa, et al.
Cellular and Molecular Life Sciences (2011) Vol. 68, Iss. 20, pp. 3385-3399
Closed Access | Times Cited: 55
Emilie Lesport, Jérémy Baudhuin, Sylvie Sousa, et al.
Cellular and Molecular Life Sciences (2011) Vol. 68, Iss. 20, pp. 3385-3399
Closed Access | Times Cited: 55
HLA-G UTR Haplotype Conservation in the Malian Population: Association with Soluble HLA-G
Federico Carlini, Karim Traoré, Nissem Cherouat, et al.
PLoS ONE (2013) Vol. 8, Iss. 12, pp. e82517-e82517
Open Access | Times Cited: 45
Federico Carlini, Karim Traoré, Nissem Cherouat, et al.
PLoS ONE (2013) Vol. 8, Iss. 12, pp. e82517-e82517
Open Access | Times Cited: 45
Role of HLA-G in Viral Infections
Simon Jasinski‐Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Simon Jasinski‐Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21